Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Gynecologic Oncology Group
With
National Cancer Institute (NCI)
PRIMARY OBJECTIVES:
I. To identify racial categorization as the proportion of genetic background of African-American or European-American women with endometrioid endometrial cancer (EEC).
II. To evaluate the association of racial genetic admixture with clinicopathologic variables and outcomes.
SECONDARY OBJECTIVES:
I. To compare the concordance between racial genetic admixture and self-designated race categorization.
OUTLINE: This is a multicenter study. Patients are stratified by race (African-American vs European-American) and disease stage (I vs II vs III vs IV).
DNA from archived frozen normal tissue samples is genotyped for the ancestry informative markers. Clinicopathological and demographic characteristics associated with each sample are also collected.
Age
Any age
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Histologically confirmed endometrial cancer
* Stage I-IV disease regardless of grade
* Underwent surgical staging including hysterectomy, bilateral oophorectomy, washings, and pelvic lymphadenectomy
Eligible and evaluated on GOG-0210 clinical trial, a Molecular Staging Study in Endometrial Cancer
Available frozen or formalin-fixed and paraffin-embedded normal tissue that is free of tumor cells and yields sufficient high-quality normal DNA for testing
Consented their specimens and clinical data to be collected and used in future studies